Home / Publications / Regioselective synthesis, structural diversification and cytotoxic activity of (thiazol-4-yl)furoxans

Regioselective synthesis, structural diversification and cytotoxic activity of (thiazol-4-yl)furoxans

16
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Kulikov A. S. et al. Regioselective synthesis, structural diversification and cytotoxic activity of (thiazol-4-yl)furoxans // Mendeleev Communications. 2018. Vol. 28. No. 6. pp. 623-625.
GOST all authors (up to 50) Copy
Kulikov A. S., Epishina M. A., Churakov A. I., Anikina L. V., Fershtat L. L., Makhova N. N. Regioselective synthesis, structural diversification and cytotoxic activity of (thiazol-4-yl)furoxans // Mendeleev Communications. 2018. Vol. 28. No. 6. pp. 623-625.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2018.11.020
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2018.11.020
TI - Regioselective synthesis, structural diversification and cytotoxic activity of (thiazol-4-yl)furoxans
T2 - Mendeleev Communications
AU - Kulikov, Alexander Sergeyevich
AU - Epishina, Margarita Alekseevna
AU - Churakov, Artem I
AU - Anikina, Lada Vladimirovna
AU - Fershtat, Leonid Leonidovich
AU - Makhova, Nina Nikolaevna
PY - 2018
DA - 2018/11/01
PB - Mendeleev Communications
SP - 623-625
IS - 6
VL - 28
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2018_Kulikov,
author = {Alexander Sergeyevich Kulikov and Margarita Alekseevna Epishina and Artem I Churakov and Lada Vladimirovna Anikina and Leonid Leonidovich Fershtat and Nina Nikolaevna Makhova},
title = {Regioselective synthesis, structural diversification and cytotoxic activity of (thiazol-4-yl)furoxans},
journal = {Mendeleev Communications},
year = {2018},
volume = {28},
publisher = {Mendeleev Communications},
month = {Nov},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2018.11.020},
number = {6},
pages = {623--625},
doi = {10.1016/j.mencom.2018.11.020}
}
MLA
Cite this
MLA Copy
Kulikov, Alexander Sergeyevich, et al. “Regioselective synthesis, structural diversification and cytotoxic activity of (thiazol-4-yl)furoxans.” Mendeleev Communications, vol. 28, no. 6, Nov. 2018, pp. 623-625. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2018.11.020.

Abstract

The effective and regioselective synthesis of new (2-hydrazinylthiazol-4-yl)furoxan hydrobromides based on the condensation of (bromoacetyl)furoxans with thiosemicarbazide has been developed. The cytotoxic activity of their derivatives (with hydrazone, 4-thiazolo[2.3-c][1,2,4]triazole or pyrrole moieties) against two human cancer cell lines (A549, HCT116) was tested and several structures revealed moderate cytotoxic activity.

References

1.
10.1016/j.mencom.2018.11.020_sbrefe0010a
Gasco
Nitric Oxide Donors: For Pharmaceutical and Biological Applications, 2005
2.
New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni
Guglielmo S., Cortese D., Vottero F., Rolando B., Kommer V.P., Williams D.L., Fruttero R., Gasco A.
European Journal of Medicinal Chemistry, 2014
3.
Antiproliferative activity and apoptosis inducing effects of nitric oxide donating derivatives of evodiamine
Zhao N., Tian K., Cheng K., Han T., Hu X., Li D., Li Z., Hua H.
Bioorganic and Medicinal Chemistry, 2016
4.
Nitric oxide-donating derivatives of hederacolchiside A 1 : Synthesis and biological evaluation in vitro and in vivo as potential anticancer agents
Fang Y., Wang R., He M., Huang H., Wang Q., Yang Z., Li Y., Yang S., Jin Y.
Bioorganic and Medicinal Chemistry Letters, 2017
7.
Ustyuzhanina N.E., Fershtat L.L., Gening M.L., Nifantiev N.E., Makhova N.N.
Mendeleev Communications, 2016
8.
Ustyuzhanina N.E., Fershtat L.L., Gening M.L., Nifantiev N.E., Makhova N.N.
Mendeleev Communications, 2018
9.
An efficient access to (1H-tetrazol-5-yl)furoxan ammonium salts via a two-step dehydration/[3+2]-cycloaddition strategy
Fershtat L.L., Epishina M.A., Kulikov A.S., Ovchinnikov I.V., Ananyev I.V., Makhova N.N.
Tetrahedron, 2015
11.
Regioselective synthesis of bifuroxanyl systems with the 3-nitrobifuroxanyl core via a one-pot acylation/nitrosation/cyclization cascade
Fershtat L.L., Larin A.A., Epishina M.A., Kulikov A.S., Ovchinnikov I.V., Ananyev I.V., Makhova N.N.
Tetrahedron Letters, 2016
12.
Side-chain prototropic tautomerism of 4-hydroxyfuroxans in methylation reactions
Fershtat L.L., Epishina M.A., Ovchinnikov I.V., Struchkova M.I., Romanova A.A., Ananyev I.V., Makhova N.N.
Tetrahedron Letters, 2016
15.
Zlotin S.G., Churakov A.M., Dalinger I.L., Luk’yanov O.A., Makhova N.N., Sukhorukov A.Y., Tartakovsky V.A.
Mendeleev Communications, 2017
16.
Design of hybrid heterocyclic systems with a furoxanylpyridine core via tandem hetero-Diels-Alder/retro-Diels-Alder reactions of (1,2,4-triazin-3-yl)furoxans
Fershtat L.L., Larin A.A., Epishina M.A., Ovchinnikov I.V., Kulikov A.S., Ananyev I.V., Makhova N.N.
RSC Advances, 2016
17.
Fershtat L.L., Radzhabov M.R., Romanova A.A., Ananyev I.V., Makhova N.N.
Arkivoc, 2017
18.
Kulikov A.S., Larin A.A., Fershtat L.L., Anikina L.V., Pukhov S.A., Klochkov S.G., Struchkova M.I., Romanova A.A., Ananyev I.V., Makhova N.N.
Arkivoc, 2017
19.
Synthesis, characterization and antibacterial activity of a Schiff base derived from cephalexin and sulphathiazole and its transition metal complexes
Anacona J.R., Rodriguez J.L., Camus J.
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2014
20.
Rapid Development of Antiretroviral Drug Resistance Mutations in HIV-Infected Children Less Than Two Years of Age Initiating Protease Inhibitor-Based Therapy in South Africa
Taylor B.S., Hunt G., Abrams E.J., Coovadia A., Meyers T., Sherman G., Strehlau R., Morris L., Kuhn L.
AIDS Research and Human Retroviruses, 2011
21.
10.1016/j.mencom.2018.11.020_bibe0035
Al-mamari
Der Pharma Chemica, 2014
22.
10.1016/j.mencom.2018.11.020_bibe0040
Siddiqui
Int. J. Pharm. Sci. Drug Res., 2009
23.
10.1016/j.mencom.2018.11.020_bibe0045
Siddiqui
Int. J. Drug Dev. Res., 2011
24.
10.1016/j.mencom.2018.11.020_bibe0050
Kapadiya
Chem. Biol. Interface, 2015
25.
10.1016/j.mencom.2018.11.020_sbrefe0055a
Chawla
Adv. J. Pharm. Life Sci. Res., 2014
26.
A facile access and evaluation of some novel thiazole and 1,3,4-thiadiazole derivatives incorporating thiazole moiety as potent anticancer agents
Gomha S.M., Abdelaziz M.R., Kheder N.A., Abdel-aziz H.M., Alterary S., Mabkhot Y.N.
Chemistry Central Journal, 2017
27.
Synthesis of N-haloacyl and N-hetarylthioacyl derivatives of 2-amino-5-aryl-6H-1,3,4-thiadiazine
Kulikova L.B., Ezhova G.I., Kravchenko N.E., Dorofeeva O.V., Kulikov A.S., Zavozin A.G.
Russian Chemical Bulletin, 2007
28.
Neuere Ergebnisse über 1,3,4-Thiadiazine
29.
10.1016/j.mencom.2018.11.020_sbrefe0065b
Busby
J. Chem. Soc., 1980
30.
α-Bromoacetyl derivatives of furazan and furoxan
Sheremetev A.B., Kulikov A.S., Khmel'nitskii L.I.
Russian Chemical Bulletin, 1993
31.
Biological Activities of Hydrazone Derivatives
Rollas S., Küçükgüzel S.
Molecules, 2007
34.
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis
Fernandes G.F., de Souza P.C., Marino L.B., Chegaev K., Guglielmo S., Lazzarato L., Fruttero R., Chung M.C., Pavan F.R., dos Santos J.L.
European Journal of Medicinal Chemistry, 2016
35.
Synthesis, antiplatelet and antithrombotic activities of resveratrol derivatives with NO-donor properties
Dutra L.A., Guanaes J.F., Johmann N., Lopes Pires M.E., Chin C.M., Marcondes S., Dos Santos J.L.
Bioorganic and Medicinal Chemistry Letters, 2017
36.
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons
Cabrera M., Mastandrea I., Otero G., Cerecetto H., González M.
Bioorganic and Medicinal Chemistry, 2016
38.
Reactions of bromoacetyl derivatives of furoxan and furazan with S-nucleophiles